Eithne Costello
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 22
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 61
- Cancer Cells and Metastasis 9
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 10
- S100 Proteins and Annexins 9
- Metabolism, Diabetes, and Cancer 9
- Immunology top 5%
- Biotechnology top 2%
-
- Pancreatitis Pathology and Treatment 14
-
- Virus-based gene therapy research 9
- Co-authors
- John P. NeoptolemosWilliam GreenhalfJörg KleeffPaula GhanehDaniel H. PalmerPatrick MichlNicholas R. LemoineTatjana Crnogorac‐Jurcevic
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Eithne Costello
106 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 1.9k
- Oncology 3.0k
- Molecular Biology 3.2k
- Immunology 817
- Biotechnology 203
Countries citing papers authored by Eithne Costello
This map shows the geographic impact of Eithne Costello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eithne Costello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eithne Costello more than expected).
Fields of papers citing papers by Eithne Costello
This network shows the impact of papers produced by Eithne Costello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eithne Costello. The network helps show where Eithne Costello may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eithne Costello, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 23 | |
| 5 | 2022 | 10 | |
| 6 | 2020 | 25 | |
| 7 | 2018 | 44 | |
| 8 | 2016 | 27 | |
| 9 | 2016 | 67 | |
| 10 | 2015 | 148 | |
| 11 | 2015 | 182 | |
| 12 | 2014 | 147 | |
| 13 | 2014 | 34 | |
| 14 | 2013 | 48 | |
| 15 | 2013 | 53 | |
| 16 | 2010 | 73 | |
| 17 | 2005 | 114 | |
| 18 | 2005 | 137 | |
| 19 | 1997 | 14 | |
| 20 | 1997 | 75 |
About Eithne Costello
Eithne Costello is a scholar working on Oncology, Cancer Research, Biotechnology, Molecular Biology and Genetics, having authored 111 papers that have together received 6.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (61 papers), Cancer Genomics and Diagnostics (22 papers), Pancreatitis Pathology and Treatment (14 papers), Epigenetics and DNA Methylation (10 papers), Virus-based gene therapy research (9 papers), Cancer Cells and Metastasis (9 papers), S100 Proteins and Annexins (9 papers) and Metabolism, Diabetes, and Cancer (9 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (3.0k citations), Molecular Biology (3.2k citations), Immunology (817 citations) and Biotechnology (203 citations). Eithne Costello has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include John P. Neoptolemos, William Greenhalf, Jörg Kleeff, Paula Ghaneh, Daniel H. Palmer, Patrick Michl, Nicholas R. Lemoine, Tatjana Crnogorac‐Jurcevic, Fiona Campbell and Christopher Halloran. Their work appears in journals such as Pancreatology, Gut, Cancer Research, Pancreas and Journal of Proteomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.